drugset
drugset / Trial / NCT05921890

To Evaluate the Safety and Tolerability of Multiple Doses of GS3-007a Oral Solution in Healthy Subjects.

NCT05921890 ↗

Phase 1 Completed 36 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelOther

Summary

To evaluate the safety and tolerability of GS3-007a oral solution after multiple oral administration in Chinese healthy adult subjects.

Timeline

Start
2023-06-19
Primary completion
2023-10-28
Completion
2023-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject GS3-007 Unknown 0.8 mg/kg Oral
Subject GS3-007 Unknown 1.6 mg/kg Oral

Indications

No indication recorded.